PD | Controls | p value | |
---|---|---|---|
N (M/F) | 93, (50/43) | 93, (47/46) | 0.66 |
Age (yrs) | 69.7 ± 8.9 | 69.6 ± 10.2 | 0.94 |
Body mass index (kg/m2) | 22.3 ± 2.8 | 22.9 ± 3.1 | 0.18 |
* RLS, n (%) | 5 (5.5) | 2 (2.2) | 0.44 |
Snoring (at least 2 days/week), n (%) | 13 (14.0) | 1 (1.1) | 0.0010 |
RBDSQ-J ≥ 5, n (%) | 27 (29.0) | 8 (8.6) | <0.001 |
RBDSQ-J ≥ 6, n (%) | 16 (17.2) | 2 (2.2) | <0.001 |
RBDSQ-J | 3.3 ± 2.5 | 1.7 ± 1.7 | <0.001 |
PSQI global score | 5.4 ± 3.7 | 4.5 ± 3.2 | 0.068 |
PSQI component score | |||
Sleep quality | 1.0 ± 0.7 | 0.8 ± 0.6 | 0.024 |
Sleep latency | 0.8 ± 1.0 | 1.0 ± 1.0 | 0.40 |
Sleep duration | 0.8 ± 0.9 | 0.8 ± 0.9 | 0.62 |
Habitual sleep efficiency | 0.5 ± 0.9 | 0.5 ± 0.8 | 0.67 |
Sleep disturbances | 0.9 ± 0.6 | 0.8 ± 0.6 | 0.47 |
Use of sleeping medication | 0.7 ± 1.2 | 0.6 ± 1.1 | 0.48 |
Daytime dysfunction | 0.7 ± 0.9 | 0.2 ± 0.4 | <0.001 |
ESS | 6.6 ± 4.5 | 4.7 ± 3.0 | <0.001 |
PDSS-2 total score | 15.0 ± 9.7 | 9.1 ± 6.6 | <0.001 |
PDSS-2 domain score | |||
Disturbed sleep | 7.6 ± 3.5 | 5.6 ± 3.4 | <0.001 |
Motor symptoms at night | 3.9 ± 4.1 | 1.8 ± 2.5 | <0.001 |
PD symptoms at night | 3.5 ± 3.6 | 1.6 ± 2.1 | <0.001 |
PDQ-39 summary index | 29.1 ± 21.7 | NA | |
PDQ-39 domain score | |||
Mobility | 40.7 ± 33.9 | NA | |
ADL | 33.0 ± 29.4 | NA | |
Emotional well-being | 29.2 ± 25.8 | NA | |
Stigma | 22.1 ± 22.4 | NA | |
Social support | 12.0 ± 20.9 | NA | |
Cognition | 23.6 ± 21.2 | NA | |
Communication | 17.3 ± 20.8 | NA | |
Bodily discomfort | 25.1 ± 24.8 | NA | |
BDI-II | 13.3 ± 9.3 | 8.5 ± 6.8 | <0.001 |
PFS | 2.8 ± 1.1 | 1.7 ± 0.8 | <0.001 |
Levodopa (mg/day) | 304.8 ± 135.5 | NA | |
LED (mg/day) | 385.1 ± 315.0 | NA |